Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guérin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naïve High-grade Non–muscle-invasive Bladder Cancer (BRIDGE)

Max Kates, Xiangying Chu, Noah Hahn, Eugene Pietzak, Angela Smith, Daniel H. Shevrin, Paul Crispen, Stephen B. Williams, Siamak Daneshmand, Vignesh T. Packiam, Sima Porten, Mary E. Westerman, Lynne I. Wagner, Michael Carducci

Research output: Contribution to journalComment/debatepeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)561-563
Number of pages3
JournalEuropean Urology Focus
Issue number4
StatePublished - Jul 2023

ASJC Scopus subject areas

  • Urology

Cite this